Monoclonal antibodies : meeting the challenges in manufacturing, formulation, delivery and stability of final drug product /

Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Shire, Steven J. (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Amsterdam : Woodhead Publishing is an imprint of Elsevier, [2015]
Colección:Woodhead Publishing series in biomedicine ; no. 77.
Temas:
Monoclonal antibodies.
Pharmaceutical technology.
Antibodies, Monoclonal > therapeutic use
Technology, Pharmaceutical
Antibodies, Monoclonal
Anticorps monoclonaux.
Techniques pharmaceutiques.
HEALTH & FITNESS > Diseases > General.
MEDICAL > Clinical Medicine.
MEDICAL > Diseases.
MEDICAL > Evidence-Based Medicine.
MEDICAL > Internal Medicine.
Pharmaceutical technology
Monoclonal antibodies
Acceso en línea:Texto completo
Descripción
Sumario:Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent. This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophy.
Descripción Física:1 online resource : illustrations (some color).
Bibliografía:Includes bibliographical references and index.
ISBN:9780081002971
0081002971

Ejemplares similares